Int. J. Mol. Sci. 2013, 14(11), 22202-22220; doi:10.3390/ijms141122202
Review

MicroRNAs and Triple Negative Breast Cancer

Start Up Unit, Experimental Oncology Department, Fondazione IRCCS Istituto Nazionale Tumori, Via Amadeo 42, Milan 20133, Italy
* Author to whom correspondence should be addressed.
Received: 2 September 2013; in revised form: 9 October 2013 / Accepted: 11 October 2013 / Published: 11 November 2013
(This article belongs to the Special Issue Molecular Bases of Cancer Research)
PDF Full-text Download PDF Full-Text [211 KB, Updated Version, uploaded 13 November 2013 16:21 CET]
The original version is still available [211 KB, uploaded 11 November 2013 11:16 CET]
Abstract: Triple Negative Breast Cancer (TNBC) is a very aggressive tumor subtype, which still lacks specific markers for an effective targeted therapy. Despite the common feature of negativity for the three most relevant receptors (ER, PgR and HER2), TNBC is a very heterogeneous disease where different subgroups can be recognized, and both gene and microRNA profiling studies have recently been carried out to dissect the different molecular entities. Moreover, several microRNAs playing a crucial role in triple negative breast cancer biology have been identified, providing the experimental basis for a possible therapeutic application. Indeed, the causal involvement of microRNAs in breast cancer and the possible use of these small noncoding RNA molecules as biomarkers has been extensively studied with promising results. Their application as therapeutic tools might represent an innovative approach, especially for a tumor subgroup still lacking an efficient and specific therapy such as TNBC. In this review, we summarize our knowledge on the most important microRNAs described in TNBC.
Keywords: microRNA; breast cancer; triple negative

Supplementary Files

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

D'Ippolito, E.; Iorio, M.V. MicroRNAs and Triple Negative Breast Cancer. Int. J. Mol. Sci. 2013, 14, 22202-22220.

AMA Style

D'Ippolito E, Iorio MV. MicroRNAs and Triple Negative Breast Cancer. International Journal of Molecular Sciences. 2013; 14(11):22202-22220.

Chicago/Turabian Style

D'Ippolito, Elvira; Iorio, Marilena V. 2013. "MicroRNAs and Triple Negative Breast Cancer." Int. J. Mol. Sci. 14, no. 11: 22202-22220.

Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert